Questions EMERGE as Biogen claims aducanumab turnaround
Crossref DOI link: https://doi.org/10.1038/s41582-019-0295-9
Published Online: 2019-11-29
Published Print: 2020-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Howard, Robert
Liu, Kathy Y.
Text and Data Mining valid from 2019-11-29
Version of Record valid from 2019-11-29
Article History
First Online: 29 November 2019
Competing interests
: The authors declare no competing interests.